Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy.

Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy. Infez Med. 2020 Sep 01;28(3):461-463 Authors: Lombardi F, Belmonti S, Borghetti A, Ciccullo A, Fabbiani M, Di Giambenedetto S Abstract Not available. PMID: 32920587 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32920587?dopt=Abstract

Source: Infezioni in Medicina - September 15, 2020 Category: Infectious Diseases Tags: Infez Med Source Type: research

More News: Infectious Diseases